Biogen Inc. (BIIB) stock
BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$250.79−0.86 (-0.34%)
Close on Nov 17, 2026Market cap $37.07BP/E 107.2Yield –
Biogen operating margin
Operating margin is operating income as a percentage of revenue.
Biogen's operating margin for the twelve months ending Mar 31, 2022 was 22.9%. For fiscal 2021 it was 25.9%, against 33.8% the year before. The highest annual figure on record is 49.0% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 25.9% | −8.0 |
| FY2020 | Dec 31, 2020 | 33.8% | −15.1 |
| FY2019 | Dec 31, 2019 | 49.0% | +5.2 |
| FY2018 | Dec 31, 2018 | 43.8% | +0.2 |
| FY2017 | Dec 31, 2017 | 43.6% | −1.4 |
| FY2016 | Dec 31, 2016 | 45.0% | −0.4 |
| FY2015 | Dec 31, 2015 | 45.4% | +4.5 |
| FY2014 | Dec 31, 2014 | 40.9% | +4.7 |
| FY2013 | Dec 31, 2013 | 36.3% | +2.6 |
| FY2012 | Dec 31, 2012 | 33.6% | −0.5 |
| FY2011 | Dec 31, 2011 | 34.2% | +7.7 |
| FY2010 | Dec 31, 2010 | 26.5% | −3.1 |
| FY2009 | Dec 31, 2009 | 29.6% | −0.0 |
| FY2008 | Dec 31, 2008 | 29.6% | +5.0 |
| FY2007 | Dec 31, 2007 | 24.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2022 | Mar 31, 2022 | 24.1% | −12.0 |
| Q4 FY2021 | Dec 31, 2021 | 21.5% | +33.1 |
| Q3 FY2021 | Sep 30, 2021 | 28.6% | −3.6 |
| Q2 FY2021 | Jun 30, 2021 | 17.5% | −36.1 |
| Q1 FY2021 | Mar 31, 2021 | 36.2% | −15.3 |
| Q4 FY2020 | Dec 31, 2020 | -11.6% | −60.0 |
| Q3 FY2020 | Sep 30, 2020 | 32.2% | −18.0 |
| Q2 FY2020 | Jun 30, 2020 | 53.6% | −0.4 |
| Q1 FY2020 | Mar 31, 2020 | 51.5% | +8.4 |
| Q4 FY2019 | Dec 31, 2019 | 48.4% | +7.5 |
| Q3 FY2019 | Sep 30, 2019 | 50.2% | +0.8 |
| Q2 FY2019 | Jun 30, 2019 | 54.1% | +17.9 |
| Q1 FY2019 | Mar 31, 2019 | 43.1% | −6.0 |
| Q4 FY2018 | Dec 31, 2018 | 40.9% | −3.4 |
| Q3 FY2018 | Sep 30, 2018 | 49.4% | −4.4 |
| Q2 FY2018 | Jun 30, 2018 | 36.1% | −2.9 |
| Q1 FY2018 | Mar 31, 2018 | 49.0% | +12.6 |
| Q4 FY2017 | Dec 31, 2017 | 44.3% | +13.4 |
| Q3 FY2017 | Sep 30, 2017 | 53.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 39.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 36.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 30.9% | – |
See a number that looks wrong?